Stockreport

Phathom Pharmaceuticals Inc (PHAT) Reports Q4 and Full Year 2023 Financials, Eyes Growth with ... [Yahoo! Finance]

Phathom Pharmaceuticals, Inc.  (PHAT) 
Last phathom pharmaceuticals, inc. earnings: 3/19 08:31 am Check Earnings Report
PDF Operating Expenses : R&D expenses were $13.4 million in Q4, with a total of $49.9 million for the year. Cash Position : PHAT ended the year with $381.4 million in cas [Read more]